Besides improving technical levels of present products, we are working hard on the research & development of new products, and taking the mimicry development of new APIs as the main direction in next several years, including Antineoplastic medicine, cardiovascular drug and nootropic. According to our researching plans, we will develop such Antineoplastic medicines as Oxaliplatin and Lobaplatin for oophoroma and cancer of rectum, pemetrexed disodium for small-cell carcinoma of the lung, Gemcitabine, Paclitaxel, Docetaxel and Irinotecan; cardiovascular drugs are atorvastatin calcium & Ezetimibe for hyperlipoidemia, Clopidogrel (antithrombotic drug), Azelnidipine for high blood pressure; nootropic includes Donepezil Hydrochloride for senile dementia, Rivastigmine and meantime hydrochloride, etc. All of them are for registration markets of these APIs, and we will pass the authentications of GMP, COS and FDA in next years. We aim to be a material production base of preparation drug factories all over the world.

There is an experienced research & development team working for us now, some of them have the college education of organic synthesis. With complete experimental condition and leading equipment, we now have the good ability to develop and research new products and methods, or provide custom-made service and contract production for customers all around the world.